Lamotte, Mark; Annemans, Lieven; Evers, Thomas; Kubin, Maria - In: PharmacoEconomics 24 (2006) 2, pp. 155-169
-transition model was developed to predict the cost effectiveness of low-dose aspirin in the primary prevention of CVD. The model … total cost was almost 3- to 4-fold higher in Spain and Italy than in the UK and Germany. Savings (non-significant) start in … the first year of treatment in all countries. Sensitivity analyses on cost of complications, utility, discounting, stroke …